Year: 2020

Selskabsmeddelelse nr. 47Fredericia, den 13. november 2020Bestyrelsesmedlem Jes Nordentoft, har valgt at udtræde af bestyrelsen pr. 25.11.2020.Om Waturu Holding A/SWaturu Holding A/S er en Greentech-virksomhed, som udvikler innovativ vandteknologi til opvarmningeller behandling af vand, med det fokus at sikre bakteriefrit vand samt nedsætte vand- og energiforbrugettil opvarmning af varmt brugsvand i ejendomme og dermed sikre CO2- besparelser. Waturu Holding A/S erhovedaktionær i medico selskabet Watgen Medical A/S samt i teknologiselskabet Aquaturu A/S.Vigtige links:www.waturu.dkwww.aquaturu.com www.watgenmedical.com 

In accordance with Article 19 of the Market Abuse Regulation, Gabriel Holding A/S publishes the following transaction.AttachmentGabriel Holding AS – Announcement no 15 Managers Transaction

I henhold til Markedsmisbrugsforordningen art. 19 offentliggør Gabriel Holding A/S følgende transaktion.Vedhæftet filGabriel Holding AS – Meddelelse nr. 15 – transaktion ledende medarbejder

VANCOUVER, British Columbia, Nov. 13, 2020 (GLOBE NEWSWIRE) — EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company”) announced today that it has signed an Equipment Purchase Agreement (the “Agreement”) with GEA Lyophil GmbH (“GEA”) to deliver a lab-scale Radiant Energy Vacuum (“REV™”) machine for the demonstration and development of REV™ technology for pharmaceutical applications.GEA will use the equipment to advance the commercialization of the technology for pharmaceutical applications. The lab-scale machine will be made available for trials with prospective pharma-industry purchasers of large-scale microwave-assisted lyophilization equipment. This machine will also be used for internal evaluation and technology advancement activities at GEA. This will allow GEA to better showcase EnWave’s technology to pharmaceutical...

At an extraordinary general meeting on 13 November 2020 the following decision was made.Decision to approve the board of directors´ resolution on the rights issue of Class A and Class B ordinary sharesThe extraordinary general meeting approved the board of directors’ resolution dated 6 October 2020 regarding the new issue of Class A and B ordinary shares with preferential rights for the holders of ordinary shares. The new issue will entail issue proceeds of approximately SEK 2 billion, before any costs relating to the new issue. The purpose is to use the issue proceeds to continue to implement the company’s strategy by giving the company room for continued value creation through selective acquisitions to the Swedish or international property portfolio as well as project development of commercial and residential premises. In addition,...

Vid en extra bolagsstämma den 13 november 2020 fattades följande beslut.Beslut om godkännande av styrelsens beslut om företrädesemission av stamaktierserie A och BDen extra bolagsstämman godkände styrelsens beslut från den 6 oktober 2020 om nyemission av stamaktier av serie A och serie B med företrädesrätt för stamaktieägarna. Nyemissionen ska avse en emissionslikvid om cirka 2 miljarder kronor, före emissionskostnader. Syftet är att använda emissionslikviden för att fortsatt verkställa bolagets strategi genom att ge bolaget utrymme för fortsatt värdeskapande genom selektiva förvärv till den svenska eller utländska fastighetsportföljen samt projektutveckling av kommersiella lokaler och bostäder. Därutöver kommer emissionslikviden ge bolaget en stärkt balansräkning, lägre belåningsgrad och ökad finansiell flexibilitet.Klövern är ett fastighetsbolag...

VANCOUVER, British Columbia, Nov. 13, 2020 (GLOBE NEWSWIRE) — SouthGobi Resources Ltd. (TSX: SGQ, HK: 1878) (“SouthGobi” or the “Company”) announces that Mr. Xiaoxiao Li (“Mr. Li”) has tendered his resignation as a non-executive director of the Company with effect from November 13, 2020.Mr. Li’s resignation as a director of the Company is a result of his recent departure from a subsidiary of a major shareholder of the Company which had nominated Mr. Li to serve as a director of the Company.Mr. Li has confirmed that he has no disagreement with the board of directors of the Company (the “Board”) and there is no matter in relation to his resignation that needs to be brought to the attention of the shareholders of the Company.The Board takes this opportunity to express its very sincere gratitude to Mr. Li for his valuable contribution...

NEW YORK, Nov. 13, 2020 (GLOBE NEWSWIRE) — Staffing 360 Solutions, Inc. (NASDAQ: STAF), a company executing an international buy-integrate-build strategy through the acquisition of staffing organizations in the United States and the United Kingdom, today announced that it has received written notice from the Nasdaq Stock Market Listing Qualifications Staff on November 12, 2020, indicating that the Company has regained compliance with the minimum bid price requirement as set forth in Nasdaq Capital Markets Listing rule 5550(a)(2). Nasdaq considers the matter closed.Brendan Flood, Chairman and Chief Executive Officer, said, “With this matter now resolved, and the previously announced recent successful restructuring of our senior debt, we continue our laser focus on driving growth and creating shareholder value.”About Staffing 360...

CARB-X and Cystic Fibrosis Foundation grants provide significant additional funding to advance CF-370 for Pseudomonas aeruginosa infectionsInitiated expanded access program with exebacase for the treatment of persistent MRSA bloodstream infections in COVID-19 patientsYONKERS, New York, Nov. 13, 2020 (GLOBE NEWSWIRE) — ContraFect Corporation (Nasdaq: CFRX) a clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides, as new medical modalities for the treatment of life-threatening, antibiotic-resistant infections, today announced financial results and business updates for the third quarter ended September 30, 2020.“We are pleased with the progress of the Phase 3 DISRUPT superiority study of exebacase, which received Breakthrough Therapy designation...